As of December 31, 2025, Lombard & Medot carries a market capitalization of 7.58M, placing it among publicly traded companies globally. Its enterprise value stands at 20.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.58M |
| Enterprise Value | 20.02M |
As of December 31, 2025, Lombard & Medot has 489,038.00 shares outstanding.
| Shares Outstanding | 489,038.00 |
These figures are as of December 31, 2025. The price-to-sales ratio is 0.78, and the price-to-book ratio stands at 0.60.
| PS Ratio | 0.78 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.64 |
These figures are as of December 31, 2025. The EV/Sales ratio of 2.06 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 20.02M versus a market cap of 7.58M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.06 |
As of December 31, 2025, Lombard & Medot maintains a current ratio of 6.30, meaning it holds 6.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 98.58, indicating elevated leverage, while an interest coverage ratio of -0.51 demonstrates limited ability to service its debt obligations.
| Current Ratio | 6.30 |
| Quick Ratio | 0.02 |
| Debt / Equity | 98.58 |
| Debt / EBITDA | -41.71 |
| Interest Coverage | -0.51 |
Over the twelve months ended December 31, 2025, Lombard & Medot posted a negative return on equity (ROE) of -8.02, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.22, reflecting losses generated across the asset base. Inventory turnover of 0.31 indicates how many times Lombard & Medot sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -8.02 |
| Return on Assets (ROA) | -3.22 |
| Inventory Turnover | 0.31 |
As of the close on October 6, 2026, Lombard & Medot's stock has gained approximately 15.49% over the past 52 weeks. The 50-day moving average sits at 14.67, while the 200-day moving average is 14.22.
| 52-Week Price Change | 15.49% |
| 50-Day Moving Average | 14.67 |
| 200-Day Moving Average | 14.22 |
Over the twelve months ended December 31, 2025, Lombard & Medot generated 9.74M in revenue and converted that into -1.06M in net income, yielding earnings per share of -2.19. EBITDA reached -300,614.00, while operating income came in at -476,591.00.
| Revenue | 9.74M |
| Gross Profit | 1.14M |
| Operating Income | -476,591.00 |
| Pretax Income | -1.07M |
| Net Income | -1.06M |
| EBITDA | -300,614.00 |
| EBIT | -476,837.00 |
| Earnings Per Share (EPS) | -2.19 |
As of December 31, 2025, Lombard & Medot holds 95,406.00 in cash and equivalents against 12.54M in total debt, resulting in a net debt position of 12.44M. Total book value stands at 12.72M, with working capital of 24.55M providing operational flexibility.
| Cash & Cash Equivalents | 95,406.00 |
| Total Debt | 12.54M |
| Net Debt | 12.44M |
| Equity (Book Value) | 12.72M |
| Book Value Per Share | 26.01 |
| Working Capital | 24.55M |
Over the twelve months ended December 31, 2025, Lombard & Medot posted a gross margin of 11.71, reflecting its pricing power and cost economics. The operating margin of -4.90 and net profit margin of -10.92 provide insight into operational efficiency.
| Gross Margin | 11.71 |
| Operating Margin | -4.90 |
| Pretax Margin | -11.00 |
| Profit Margin | -10.92 |
| EBITDA Margin | -3.09 |
As of December 31, 2025, Lombard & Medot has an Altman Z-Score of 1.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.36 |
Already premium?